Empowering you to elevate care—even for your most vulnerable patients
Regular blood glucose testing in hospitals is vital to identify dangerous imbalances and adjust treatment, preventing life-threatening situations and long-term complications.1-4 The alarming rise in diabetes, coupled with strained healthcare systems, demands innovative, highly accurate blood glucose solutions—now more than ever.
Help improve patient outcomes and ensure high-quality patient care with our advanced glucose Point of Care testing solutions for accurate blood glucose results in professional settings. With a focus on digital health, we strive to create solutions that not only help to improve glucose Point of Care testing but also revolutionize the way we provide care.
From Accu-Chek® Inform II to the cobas® pulse system*, you get high-performing Point of Care glucose testing solutions—and more. The innovative cobas® pulse system* comes with cutting-edge technology, is customizable through mobile health apps, and integrates easily into existing infrastructures. Together with our navify® POC digital solutions, you gain valuable medical insights to help optimize patient care and simplify hospital workflows. Ensure high serviceability and compliance with strict regulations, empower better reporting and analysis, and improve your operational efficiency—all while maintaining central lab control.
Featured products
Benefits of hospital blood glucose POC testing solutions from Roche
Discover smart functions and tools to make your work life easier
- Promote ease of use and simplified learning: The intuitive icon-based interface on cobas® pulse* and the device-guided test process with color changes between each step, ensures fast and easy operation and is designed to help train new staff faster.
- Provide centralized control: navify® POC digital solutions enable hospital staff to manage devices from a centralized lab or a decentralized location to orchestrate POC operations. This enables remote troubleshooting, simplifying software updates and ongoing monitoring, while helping you stay compliant and facilitate accreditation.
Elevate patient experience and drive better care
- Improve patient care: Regular blood glucose monitoring in hospitals is vital in helping to prevent and manage dysglycemia, which can increase complications, mortality, and healthcare costs.1-4 Additionally, 15% of newborns experience hypoglycemia, posing serious health risks if left unrecognized and untreated.5
- Harness the power of digitally enhanced solutions: Optimize treatments and aid decision-making with a growing collection of Roche-selected mobile health apps and data-driven health insights.
- Trust in reliable results: Cutting-edge technology and a unique, advanced strip architecture deliver advanced results and accuracy.6
- Accuracy that meets the latest guidelines: The high-performing POC hospital glucose monitoring system cobas® pulse* is the only device evaluated and FDA-cleared under the latest guidelines for hospital blood glucose systems.7

Introducing the cobas® pulse system*
Delivering proven results you can trust from a company you know, the cobas® pulse* system is an app-based, user-friendly blood glucose management solution that provides a gateway to the future of digital health at the point-of-care (POC).
Related health topics
*cobas® pulse is not currently available for sale in the US and not intended for use with capillary fingerstick or venous samples.
Images on this page are used for illustrative purposes only; any person depicted in the content is a model.
References
- Pasquel FJ et al. Management of diabetes and hyperglycaemia in the hospital. Lancet Diab Endocrinol. 2021; 9(3):174-88.
- American Diabetes Association. Standards of Diabetes Care in Diabetes. 2021; 44: Suppl 1, S15-S33.
- Dhatariya K et al. NCBI Bookshelf. Management of Diabetes and Hyperglycemia in Hospitalized Patients. 2020.
- Hermanides J et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010; 38(3):838-842.
- Roeper M et al. Neonatal hypoglycemia: lack of evidence for a safe management. Front Endocrinol (Lausanne). 2023; 14:1179102.
- Roche cobas® GLU test strips Method Sheet, v 3.0, 2023.
- FDA Guidance Document: Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use (2020), document number 1755.